Maven Securities LTD

SEC CIK: 0001633046
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

NTLA holding history

Intellia Therapeutics, Inc. in every 13F filed by Maven Securities LTD, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NTLA overview All 13F holders of NTLA Full Q2 2026 holdings

Shares (Q3 2021): 0; Sold out in Q3 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of NTLA by Maven Securities LTD, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2021	0	$0	0.0%	−6,146−100.0%	Sold out	Holders
Q2 2021	6,146	$1.22M	0.1%	−20,142−76.6%	Reduced	Holders
Q1 2021	26,288	$2.08M	0.2%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.